Use of the corticoliberin-urocortin system in the treatment of inflammatory diseases

Details for Australian Patent Application No. 2003302368 (hide)

Owner Bionature E.A. Limited

Inventors Gravanis, Achille; Margioris, Andrew N.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2003302368

PCT Number PCT/IB2003/0054

PCT Pub. Number WO2004/047866

Priority 20020100513 26.11.02 GR

Filing date 26 November 2003

Wipo publication date 18 June 2004

Acceptance publication date 11 October 2007

International Classifications

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61K 38/22 (2006.01) Medicinal preparations containing peptides - Hormones

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

Event Publications

15 July 2004 Complete Application Filed

  Priority application(s): 20020100513 26.11.02 GR

22 July 2004 Application Open to Public Inspection

  Published as AU-B-2003302368

11 October 2007 Application Accepted

  Published as AU-B-2003302368

7 February 2008 Standard Patent Sealed

24 June 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003302369-METHODS OF ANALYZING ATRIAL FIBRILLATIONS

2003302367-Method and device to control and condition the behavior of the Varroa destructor mite in a beehive, or in other environment where bees reproduce